Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Roche Molecular Systems, Inc.
*MAILING ADDRESS
4300 HACIENDA DRIVE
*CITY
PLEASANTON
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
94588
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
001
*IDENTIFICATION
In vitro diagnostic agents, namely, chemical control solutions for calibrating and monitoring the accuracy and function of instruments and
test results, chemical additives, enzymes, reagents, organisms and proteins for use in science, research and industry; reagents for cell separation for scientific or research purposes; labeling
reagents for scientific or research purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in
particular of chemicals and biological material, all for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or
research purposes; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus, for scientific or research purposes; reagents for processing
biological material, namely, tissue, bone marrow, cells, blood and components thereof for scientific or research purposes; reagents, enzymes, and nucleotides for nucleic acid sequencing for
scientific or research purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or
medical research use for analyzing cells, proteins, nucleic acids, sequencing dna, genotyping, gene expression profiling and high through-put screening; reagent kits composed primarily of
oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research; nucleic acids, enzymes, buffers and chemical reagents for use in
genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests
and test kits primarily composed of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research
use in connection with dna sequencing and genetic analysis
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
005
*IDENTIFICATION
In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes;
reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and
modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for testing body fluids to determine fetal chromosomal
abnormalities; chemical reagents, preparations and test kits for fetal nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis
for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with dna sequencing and genetic
analysis
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
009
*IDENTIFICATION
Scientific equipment, apparatus and instruments, namely, genome sequencer for scientific, pharmaceutical and medical research purposes;
scientific instruments for use in scientific research, namely, nucleic acid sequencers, imaging devices and analyzers; laboratory apparatus for sample preparation, amplification, mixing,
hybridization, incubation, and washing, namely, arrays, beads, bead sets and flow cells; laboratory equipment, namely, devices for analysis of nucleic acids and for dna sequencing; automated
laboratory apparatus and systems, namely, sample loaders and bar code readers; Software used for genotyping and gene expression microarrays for scientific, pharmaceutical and medical research
purposes; software used in analyzing, managing and visualizing dna sequencing data; software used for preparation of nucleic acids libraries; computer hardware and software for collecting, storing,
analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, for use in the fields of scientific, diagnostic and clinical research and
for clinical diagnostic purposes
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Kenneth J. Waite
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Roche Diagnostics Operations, Inc.
STREET
9115 Hague Road
CITY
Indianapolis
STATE
Indiana
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
46250
PHONE
317-521-3104
EMAIL ADDRESS
indianapolis.trademarks@roche.com
CORRESPONDENCE INFORMATION
NAME
Kenneth J. Waite
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
indianapolis.trademarks@roche.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
3
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEES DUE
825
*TOTAL FEES PAID
825
SIGNATURE INFORMATION
SIGNATURE
/kjw/
SIGNATORY'S NAME
Kenneth J. Waite
SIGNATORY'S POSITION
Attorney of record, Indiana bar member
SIGNATORY'S PHONE NUMBER
317-521-3104
DATE SIGNED
06/10/2020
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88957967
Filing Date:06/10/020
To the Commissioner for Trademarks:
MARK: SBX (Standard Characters, see mark)
The literal element of the mark consists of SBX. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Roche Molecular Systems, Inc., a corporation of Delaware, having an address of
4300 HACIENDA DRIVE
PLEASANTON, California 94588
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 001: In vitro diagnostic agents, namely, chemical control solutions for calibrating and monitoring the accuracy and function of instruments and test results, chemical
additives, enzymes, reagents, organisms and proteins for use in science, research and industry; reagents for cell separation for scientific or research purposes; labeling reagents for scientific or
research purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemicals and
biological material, all for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or research purposes; buffer
solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus, for scientific or research purposes; reagents for processing biological material,
namely, tissue, bone marrow, cells, blood and components thereof for scientific or research purposes; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or research
purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or medical research use
for analyzing cells, proteins, nucleic acids, sequencing dna, genotyping, gene expression profiling and high through-put screening; reagent kits composed primarily of oligonucleotides, enzymes and
buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research; nucleic acids, enzymes, buffers and chemical reagents for use in genotyping and gene expression
test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests and test kits primarily composed
of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research use in connection with dna
sequencing and genetic analysis
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 005: In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical
diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides,
buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for testing body fluids to determine fetal chromosomal abnormalities; chemical
reagents, preparations and test kits for fetal nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic
purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with dna sequencing and genetic analysis
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 009: Scientific equipment, apparatus and instruments, namely, genome sequencer for scientific, pharmaceutical and medical research purposes; scientific instruments for use
in scientific research, namely, nucleic acid sequencers, imaging devices and analyzers; laboratory apparatus for sample preparation, amplification, mixing, hybridization, incubation, and washing,
namely, arrays, beads, bead sets and flow cells; laboratory equipment, namely, devices for analysis of nucleic acids and for dna sequencing; automated laboratory apparatus and systems, namely, sample
loaders and bar code readers; Software used for genotyping and gene expression microarrays for scientific, pharmaceutical and medical research purposes; software used in analyzing, managing and
visualizing dna sequencing data; software used for preparation of nucleic acids libraries; computer hardware and software for collecting, storing, analyzing and reporting biological information, and
for sample tracking and managing projects, laboratory workflow and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Kenneth J. Waite. Kenneth J. Waite of Roche Diagnostics Operations, Inc., is a member of the XX bar, admitted to the bar in XXXX, bar
membership no. XXX, is located at
9115 Hague Road
Indianapolis, Indiana 46250
United States
317-521-3104(phone)
indianapolis.trademarks@roche.com
Kenneth J. Waite submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Kenneth J. Waite
PRIMARY EMAIL FOR CORRESPONDENCE: indianapolis.trademarks@roche.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT
PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: /kjw/ Date: 06/10/2020
Signatory's Name: Kenneth J. Waite
Signatory's Position: Attorney of record, Indiana bar member
Payment Sale Number: 88957967
Payment Accounting Date: 06/10/2020
Serial Number: 88957967
Internet Transmission Date: Wed Jun 10 14:32:51 ET 2020
TEAS Stamp: USPTO/BAS-XXX.XX.XX.XXX-2020061014325114
3646-88957967-7105b475dbfec6ec1ba8d25a29
a4aa31d7ce86538d869f077a230b48599890f18a
-DA-32506692-20200610143103618909